Placebo-Controlled, Double-Blind Study of Empagliflozin (EMPA) and Implantable Cardioverter-Defibrillator (EMPA-ICD) in Patients with Type 2 Diabetes (T2DM): Rationale and DesignTohru Minamino, Shinichi Niwano, Kenichi Tsujita et al.|Diabetes Therapy|2020Cited by 21
MOESM2 of Adult ALCAPA: from histological picture to clinical featuresHiroshi Kubota, Kenichi Sudo, Hidehito Endo et al.|Figshare|2020Cited by 0